Novel anticancer targets and drug discovery in post genomic age

Current Medicinal Chemistry - Anti-Cancer Agents

Volumn 5, Issue 1, 2005, Pages 53-63

  Li, Qianbin ^a   Xu, Wenfang ^a  

^a SHANDONG UNIVERSITY   (China)

Author keywords

Aminopeptidase N; Farnesyltransferase; Inhibitor manipulators; Matrix metalloproteinases; Novel anticancer targets; Tyrosine kinase

Indexed keywords

2,4 DIMETHYL 5 (2 OXO 1H INDOL 3 YLMETHYLENE) 3 PYRROLEPROPIONIC ACID; 3 AMINO 2 HYDROXY 4 PHENYLBUTYRIC ACID; ANGIOGENESIS INHIBITOR; ANTINEOPLASTIC AGENT; CETUXIMAB; CGS 27023A; CILENGITIDE; ERLOTINIB; GEFITINIB; GELATINASE A; GELATINASE B; IMATINIB; MARIMASTAT; MATRIX METALLOPROTEINASE; MATRIX METALLOPROTEINASE INHIBITOR; MICROSOMAL AMINOPEPTIDASE; MONOCLONAL ANTIBODY LM 609; OSI 7740; PRINOMASTAT; PROTEIN FARNESYLTRANSFERASE; PROTEIN TYROSINE KINASE; PYRROLIDINE DERIVATIVE; RITUXIMAB; SEMAXANIB; TANOMASTAT; TEMOZOLOMIDE; THALIDOMIDE; TRASTUZUMAB; UNCLASSIFIED DRUG; UNINDEXED DRUG; VANDETANIB; VATALANIB;

BRONCHOSPASM; CANCER; CANCER GROWTH; CANCER PAIN; CARDIOTOXICITY; CLINICAL TRIAL; DIARRHEA; DRUG DESIGN; DRUG ERUPTION; DRUG HYPERSENSITIVITY; DRUG RESEARCH; DRUG STRUCTURE; DRUG SYNTHESIS; DRUG TARGETING; DYSPNEA; EDEMA; FATIGUE; FEVER; GENOMICS; HUMAN; HYPERTENSION; HYPOTENSION; IC 50; LIVER TOXICITY; MACROMOLECULE; METASTASIS; NAUSEA; REVIEW; SEQUENCE ANALYSIS; SIGNAL TRANSDUCTION; THROMBOCYTOPENIA; TUMOR VASCULARIZATION; VOMITING;

ALKYL AND ARYL TRANSFERASES; ANGIOGENESIS INHIBITORS; ANTIGENS, CD13; ANTINEOPLASTIC AGENTS; CYCLOOXYGENASE 2; DRUG DESIGN; FARNESYLTRANSTRANSFERASE; GENOMICS; HISTONE DEACETYLASES; HSP90 HEAT-SHOCK PROTEINS; INTEGRINS; MATRIX METALLOPROTEINASES; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; PROTEIN-TYROSINE KINASES; RECEPTORS, ENDOTHELIN; SIGNAL TRANSDUCTION;

EID: 11444269801     PISSN: 15680118     EISSN: None     Source Type: Journal    
DOI: 10.2174/1568011053352631     Document Type: Review

References (71)

1. Zetter, B.R. Annu. Rev. Med., 1998, 49, 407.
2. Fontanini, G.; Boldrini, L.; Chine, S.; Pisaturo, F.; Basolo, F.; Calcinai, A.; Lucchi, M.; Mussi, A.; Angeletti, C.A.; Bevilacqua, G. Br. J. Cancer, 1999, 79, 363.
3. Tamurea, M.; Gu, J.; Tran, H.; Yamada, K.M. J. Natl. Cancer. Inst., 1999, 91, 1820.
4. Westlin, W.F. Cancer J., 2001, 7 (Suppl. 3), 139.
5. Kerr, J.S.; Slee, A.M.; Mousa, S.A. Expert. Opin. Investig. Drugs, 2002, 11, 1765.
6. Kerr, J.S.; Mousa, S.A.; Slee, A.M. Drug News Perspect. 2001, 14, 143.
7. Horton, M.A. Exp. Nephrol., 1999, 7, 178.
8. Tremont-Lukats, I.W.; Gilbert, M.R. Cancer Control, 2003, 10, 125.
9. Posey, J.A.; Khazaeli, M.B.; DelGrosso, A.; Saleh, M.N.; Lin, C.Y.; Huse, W.; LoBuglio, A.F. Cancer Biother. Radiopharm., 2001, 16, 125.
10. Taga, T.; Suzuki, A.; Gonzalez-Gomez, I.; Gilles, F.H.; Stins, M.; Shimada, H.; Barsky, L.; Weinberg, K.I.; Laug, W.E. Int. J. Cancer, 2002, 98, 690.
11. Hidalgo, M.; Eckhardt, S.G. J. Natl. Cancer. Inst., 2001, 93, 178.
12. Skiles, J.W.; Gonnella, N.C.; Jeng. A.Y. Curr. Med. Chem. 2001, 8, 425.
13. Stamenkovic, I. Semin. Cancer Biol., 2000, 10 415.
14. Ramnath, N.; Creaven, P.J. Curr. Oncol. Rep., 2004, 6, 96.
15. Sridhar, S.S.; Shepherd, F.A. Lung Cancer. 2003, 42 (Suppl. 1), 81.
16. Bramhall, S.R.; Hallissey, M.T.; Whiting, J.; Scholefield, J.; Tierney, G.; Stuart, R.C.; Hawkins, R.E.; McCulloch, P.; Maughan, T.; Brown, P.D.; Baillet, M,; Fielding, J.W. Br. J. Cancer, 2002, 86, 1864.
17. Xu, W.F. 226th ACS National Meeting, 2003, 7.
18. Atalay, G.; Cardoso, F.; Awada, A.; Piccart, M.J. Ann. Oncol., 2003, 14, 1346.
19. Redemann, N.; Holzmann, B.; von Ruden, T.; Wagner, E.F.; Schlessinger, J.; Ullrich, A. Mol. Cell. Biol., 1992, 12 491.
20. Fabbro, D.; Manley, P.W. Curr. Opin. Investig. Drugs, 2001, 2, 1142.
21. Hoekman, K. Cancer J., 2001, 7(Suppl. 3), 134 s.
22. Klem, J. Clin. Colorectal Cancer, 2003, 3, 147.
23. Wedge, S.R.; Ogilvie, D.J.; Dukes, M.; Kendrew, J.; Chester, R.; Jackson, J.A.; Boffey, S.J.; Valentine, P.J.; Curwen, J.O.; Musgrove, H.L.; Graham, G.A.; Hughes, G.D.; Thomas, A.P.; Stokes, E.S.; Curry, B.; Richmond, G.H.; Wadsworth, P.F.; Bigley, A.L.; Hennequin, L.F. Cancer Res., 2002, 62, 4645.
24. Ross, J.S.; Gray, G.S. Clin. Leadersh. Monag. Rev., 2003, 17, 333.
25. Ferrone, M.; Motl, S.E. Ann. Pharmacother., 2003, 37, 1904.
26. Grillo-López, A.J. Expert. Rev. Anticancer Ther., 2003, 3, 767.
27. Herbst, R.S.; Hong, W.K. Semin. Oncol., 2002, 29 (Suppl. 14), 18.
28. Cobleigh, M.A.; Langmuir, V.K.; Sledge, G.W.; Miller, K.D.; Haney, L.; Novotny, W.F.; Reimann, J.D.; Vassel, A. Semin. Oncol., 2003, 30 (Suppl. 16), 117.
29. Gibbs, R.A.; Zahn, T.J.; Sebolt-Leopold, J.S. Curr. Med. Chem., 2001, 8, 1437.
30. Singh, S.B.; Lingham, R.B. Curr. Opin. Drug. Discov. Devel., 2002, 5, 225.
31. Feldkamp, M.M.; Lau, N.; Roncari, L.; Guha, A. Cancer Res. 2001, 61, 4425.
32. Johnston, S.R.; Hickish, T.; Ellis, P.; Houston, S.; Kelland, L.; Dowsett, M.; Salter, J.; Michiels, B.; Perez-Ruixo, J.J.; Palmer, P.; Howes, A. J. Clin. Oncol., 2003, 21, 2492.
33. Van Cutsem, E.; van de Velde, H.; Karasek, P.; Oettle, H.; Vervenne, W.L.; Szawlowski, A.; Schoffski, P.; Post, S.; Verslype, C.; Neumann, H.; Safran, H.; Humblet, Y.; Perez Ruixo, J.; Ma, Y.; Von Hoff, D. J. Clin. Oncol., 2004, 22, 1430.
34. Kelland, L.R. Expert. Opin. Investig. Drugs, 2003, 12, 413.
35. Look, A.T.; Ashmun, R.A.; Shapiro, L.H.; Peiper, S.C. J. Clin. Invest., 1989, 83, 1299.
36. Pasqualini, R.; Koivunen, E.; Kain, R.; Lahdenranta, J.; Sakamoto, M.; Stryhn, A.; Ashmun, R.A.; Shapiro, L.H.; Arap, W.; Ruoslahti, E. Cancer Res., 2000, 60, 722.
37. Sato, Y. Biol. Pharm. Bull., 2004, 27, 776
38. Riemann, D.; Kehlen, A.; Langner, J. Immunol. Today, 1999, 20, 83.
39. Hopper, N.M. FEBS. Lett., 1994, 354, 1.
40. Saiki, I.; Fujii, H.; Yoneda, J.; Abe, F.; Nakajima, M.; Tsuruo, T.; Azuma, I. Int. J. Cancer, 1993, 54, 137.
41. Menrad, A.; Speicher, D.; Wacker, J.; Herlyn, M. Cancer Res., 1993, 53, 1450.
42. Santos, A.N.; Langner, J.; Herrmann, M.; Riemann, D. Cell. Immunol., 2000, 201, 22.
43. Delmas, B.; Gelfi, J.; L'Haridon, R.; SjöströmNorén, H.; Laude, H. Nature, 1992, 357, 417.
44. Yeager, C.L.; Ashmun, R.A.; Williams, R.K.; Cardellichio, C.B.; Shapiro, L.H.; Thomas Look. A.; Holmes, K.V. Nature, 1992, 357, 420.
45. Wang, J.L.; Xu, W.F. J. Chem. Res. Synop., 2003, 789.
46. Ma, T.; Xu, W.F.; Wang, J.L.; Yuan, Y.M. Chinese J. Med. Chem., 2003, 13, 70.
47. Ino, K.; Bierman, P.J.; Varney, M.L.; Heimann, D.G.; Kuszynski, C.A.; Walker, S.A.; Talmadge, J.E. Cancer Immunol. Immunother., 1996, 43, 206.
48. Ichinose, Y.; Genka, K.; Koike, T.; Kato, H.; Watanabe, Y.; Mori, T.; Iioka, S.; Sakuma, A.; Ohta, M. J. Nat. Cancer. Inst., 2003, 95, 605.
49. Miller, T.A.; Witter, D.J.; Belvedere, S. J. Med Chem., 2003, 46, 5097.
50. Curtin, M.L.; Garland, R.B.; Heyman, H.R.; Frey, R.R.; Michaelides, M.R.; Li, J; Pease, L.J.; Glaser, K.B.; Marcotte, P.A.; Davidsen, S.K. Bioorg. Med. Chem. Lett., 2002, 12, 2919.
51. Komatsu, Y.; Tomizaki, K; Tsukamoto, M.; Kato, T.; Nishino, N.; Sato, S.; Yamori, T.; Tsuruo, T.; Furumai, R.; Yoshida, M.; Horinouchi, S.; Hayashi, H. Cancer Res., 2001, 61, 4459.
52. Kelly, W.K.; Richon, V.M.; O'Connor, O.; Curley, T.; MacGregor-Curtelli, B.; Tong, W.; Klang, M.; Schwartz, L.; Richardson, S.; Rosa, E.; Drobnjak, M.; Cordon-Cordo, C.; Chiao, J.H.; Rifkind. R.; Marks, P.A.; Scher, H. Clin. Cancer Res., 2003, 9, 3578.
53. Banerji, U.; Judson, I.; Workman P. Curr. Cancer Drug Targets, 2003, 3, 35.
54. Kamal, A.; Thao, L.; Sensintaffar, J.; Zhang, L.; Boehm, M.F.; Fritz, L.C.; Burrows, F.J. Nature, 2003, 425, 407.
55. Dannenbeig, A.J.; Altorki, N.K.; Boyle, J.O.; Dang, C.; Howe, L.R.; Weksler, B.B.; Subbaramaiah, K. Lancet Oncol., 2001, 2, 544.
56. Cao, Y.; Prescott, S.M. J. Cell. Physiol., 2002, 190, 279.
57. Fenwick, S.W.; Toogood, G.J.; Lodge, J.P.A.; Hull, M.A. Gastroenterology, 2003, 125, 716.
58. He, Q.; Lapointe, M.C. Hypertension, 2001, 37 478.
59. Bagnato, A.; Natali, P.G. J. Transl. Med., 2004, 2, 16.
60. Zonnenber, B.A.; Groenewegen, G.; Janus, T.J.; Leahy, T.W.; Humerickhouse, R.A.; Isaacson, J.D.; Carr, R.A.; Voest, E. Clin. Cancer Res., 2003, 9, 2965.
61. Lee, D. Clin. Prostat Cancer, 2003, 2, 84.
62. Fisher, M. Clin. Prostat Cancer, 2002, 1, 79.
63. Adams, J.; Palombella, V.J.; Sausville, E.A.; Johnson, J.; Destree, A.; Lazarus, D.D.; Maas, J.; Pien, C.S.; Prakash, S.; Elliott, P.J. Cancer Res., 1999, 59, 2615.
64. Bleicher, K.H. Curr. Med. Chem., 2002, 9, 2077.
65. Bredel, M; Jacoby, E. Nat. Rev. Genet., 2004, 5, 262
66. Nislow, C.; Giaever, G. Pharmacogenomics, 2003, 4, 15.
67. Kwon, H.J.; Owa, T.; Hassig, C.A.; Shimada, J; Schreiber, S.L. Proc. Natl. Acad. Sci. U.S.A., 1998, 95, 3356.
68. Wittich, S.; Scherf, H.; Xie, C.; Brosch, G.; Loidl, P.; Gerhäuser, C.; Jung, M. J. Med. Chem., 2002, 45, 3296.
69. Han, C.K., Ahn, S.K.; Choi, N.S.; Hong, R.K.; Moon, S.K.; Chun, H.S.; Lee, S.J.; Kim, J.W.; Hong, C.I.; Kim,D.; Yoon, J.H.; No, K.T. Bioorg. Med. Chem. Lett., 2000, 10, 39.
70. Soga, S.; Neckers, L.M.; Schulte, T.W.; Shiotsu, Y.; Akasaka, K.; Narumi, H.; Agatsuma, T.; Ikuina, Y.; Murakata, C.; Tamaoki, T.; Akinaga, S. Cancer Res., 1999, 59, 2931.
71. Müller, C.; Gourzoulidou, E.; Carpintero, M.; Karaguni, I.; Langerak, A.; Herrmann, C.; Möröy, T.; Klein-Hitpa_, L.; Waldmann, H. Angew. Chem. Int. Ed. Engl., 2004, 43, 450.